Specifications

Value of the Data
These data give an overview of the relative Cre mRNA expression in the retina as well as the genomic recombination efficiency in brain and bone marrow and the Cre and VEGF-A mRNA expression in brain, bone marrow and lung as part of the validation of the VEGF fl/fl LysMCre (here named VEGF mcko ) knockout mouse model. These data are important for the use of the same knockout mouse in other studies.
Flow cytometric data providing an overview of T memory cells, natural killer (NK) cells, and natural killer-T (NKT) cells as percentage of CD45 positive cells in the retina of knockout and control retinas under normoxic and hypoxic conditions are presented.
The presented pathological retinal features in the model of oxygen-induced retinopathy in clodronate-liposome treated mice is of interest for similar studies.
Data
Seven-day-old pups and the nursing dam were exposed to a 75% oxygen containing environment for five days before replacement in normal housing conditions causing a neovascular stimulus via relative hypoxia until further analysis on postnatal days 14 and 17. The oxygen box was opened daily for a very short period to check on pups and mother.
Experimental design, materials, and methods
The experimental procedures are described in the related research article: Nürnberg et al. [1] (Table 1) . A more detailed description of some of the methods used in this article as followed Figs. 1-8:
Material and methods
Mouse model of oxygen induced retinopathy
Oxygen Induced Retinopathy (OIR) was induced as described in the main text with few modifications ( Fig. 1 ). The nursing dam as well as the offspring was kept under normal housing conditions from day P0 to P7. On day P7 the animals were exposed to a 75% oxygen containing environment for five days using a special oxygen chamber (Model THF3384, EHRET Labor-u. Pharmatechnik GmbH, Emmendingen, Germany). In contrast to the original protocol [2] , the oxygen chamber was opened once daily for a few minutes to check on dam and pups. On P12 the mice were transferred back into normal housing conditions until P14 or P17 for analysis. A surrogate dam was provided if the nursing dam passed awaya very rare occurrence though. Room air controls were kept under normal housing conditions at all times. All non-liposome treated mice were genotyped twice: on P12 ear punch tissue was used for DNA isolation. All animals were re-genotyped after completion of the experiment by tail tip biopsy. For the VEGF-A flox PCR the following primers were used: muVEGF419.F (5′-CCTGGCCCTCAAGTACACCTT-3′); muVEGF567.R (5′-TCCGTACGACGCATTTCTAG-3′). In the presence of a loxP-1 site these primers generated a 168 bp long fragment, and an approximately 100 bp long band in the wildtype. Evidence of the LysMCre transgene was shown using the following primers: IMR3066 (5′-CCCAGAAATGCCAGATTACG-3′); IMR3067 (5′-CTTGGGCTG CCAGAATTTCTC-3′); IMR3068 (5′-TTACAGTCGGCCAGGCTGAC-3′). Presence of the transgene was indicated by a 700 bp long band and the presence of a wildtype allele by a 350 bp long band.
Mouse organ dissection
Organs of mice were dissected for various reasons including genomic PCR, mRNA expression level analysis, histological analysis and flow cytometry. All mice were first narcotized using a mixture of 10 mg/g bodyweight ketamine (Ketamine-Actavis®, Actavice Group PTC ehf., Hafnarfjördur, Island) and 0.015 mg/g bodyweight xylazine (CP-Pharma, Burgdorf, Germany) and then euthanized by cervical dislocation, and the tail tip was cut off for the second confirmation of the genotype. Both the femoral and the tibial bone were extracted from the leg, the bone marrow flushed out with a 20G syringe needle (B. Braun, Melsungen, Germany) into the tube with PBS, and centrifuged at 1400 rpm for five minutes. The thorax was cut open and thyme, spleen as well as the lungs were dissected and cleaned from blood as best as possible. The eyes were enucleated and dissected under microscopic control. Cornea and lens were removed and the retina carefully dissected out of the eyecup removing vitreous body and RPE cells as best as possible. Finally, the skull was cut open, the brain extracted and cut into halves.
DNA isolation for genotyping
For purification of total genomic DNA from different mouse tissues, the DNeasy Blood and Tissue Kit (Qiagen, Hilden, Germany) was used and the manufacturer's instructions were followed.
mRNA expression levels
For reverse transcription of cDNA, the "High-Capacity cDNA Reverse Transcription Kit" (Applied Biosystems, Darmstadt, Germany) was used and the manufacturer's instructions were followed. In this experimental setup, β-Actin was chosen as the housekeeping gene for control since oxygen treatment influences the expression levels of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in vitro [3] . Transcripts of interest were cDNAs encoding Cre and VEGF-A in the retina, bone marrow or brain. SensiFAST SYBR (BIOLINE, Luckenwalde, Germany) was used for quantitative Real-Time PCR purposes, and the manufacturer's instructions were followed. The following primers were used: VEGF-A fwd (5′-CAGCTATTG CCGTCCGATTGA GA-3′) and VEGF-A rev (5′-TGC TGG CTT TGG TGA GGT TTG AT-3′) amplifying a 201 bp long product; Cre fwd (5′-GATTTCGACCAGGTTCGTTC-3′) and Cre rev (5′-GCT AACCAGCGTTTTCGTTC-3′); β-Actin fwd (5′-AAGGCCAACCGTGAAAAGAT-3′) and β-Actin rev (5′-GTGGTACGACCAGAGGCATAC). The samples were analyzed in a LightCycler 480 and calculations were performed using the LightCycler software (Roche, Basel, Switzerland). All samples were run in triplicates and the melting curve of each product was monitored and probes with unspecific melting curves were excluded from the analysis. In order to verify the specificity of the primers that were used, amplification products were separated on a 2% agarose gel, the DNA bands were purified from the agarose using QIAquick Gel Extraction Kit (Qiagen) and the manufacturer's instructions were followed before sequencing. Due to a very high amount of mRNA yield, the beta-Actin primers bound at a second binding site within the beta-Actin sequence, causing double peak melting curve. Sequencing of both peaks revealed that both products were beta-Actin products. Also the other products were primer specific. VEGF mcko n ¼ 8; 2.0 71.14%; control n ¼ 9; 1.56 7 0.64%; P17 hypoxia: VEGF mcko n ¼5; 1.23 7 0.78%; control n ¼7; 1.16 70.38%. P14 normoxia: VEGF mcko n ¼ 15; 0.55 7 0.48%; control n ¼6; 0.417 0.41%; P17 normoxia: VEGF mcko n ¼10; 0.2 7 0.08%; control n ¼7; 0.13 70.07%. (B) NK cells as percentage of CD45 positive cells (% NK1.1 þ CD3of CD45 þ cells): P14 hypoxia: VEGF mcko n ¼6; 2.36 7 2.61%; control n ¼ 7; 0.8 7 1.71%. P14 normoxia VEGF mcko n ¼ 12; 0.32 7 1.67%; control n ¼ 6; 0.26 70.27%. P17 hypoxia VEGF mcko n ¼5; 0.247 0.11%; control n ¼7; 0.477 0.17%. P17 normoxia VEGF mcko n ¼10; 0.12 7 0.05%; control n ¼ 7; 0.12 70.07%. (C) NKT cells as percentage of CD45 positive cells (% NK1.1 þ CD3 þ of CD45 þ cells): P14 hypoxia: VEGF mcko n ¼ 8; 13.917 11.24%; control n ¼9; 13.02 7 4.92%. P17 hypoxia: VEGF mcko n ¼ 5; 5.117 1.35%; control n ¼ 7; 4.53 7 1.47%. P14 normoxia: VEGF mcko n ¼ 15; 6.7 74.43%; control n¼ 8; 4.83 7 3.93%. P17 normoxia: VEGF mcko n ¼10; 0.36 7 0.23%; control n ¼ 7; 0.12 70.07%. Oberländer for embedding and cutting the paraffin sections, and to Gabriele Fels for support in conducting some immunostainings.
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